BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11346322)

  • 21. A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults.
    Söderquist F; Syk M; Just D; Kurbalija Novicic Z; Rasmusson AJ; Hellström PM; Ramklint M; Cunningham JL
    BMC Psychiatry; 2020 Nov; 20(1):535. PubMed ID: 33176747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of an Individual Educational Program on the Quality of Life and Severity of Symptoms of Patients with Irritable Bowel Syndrome.
    Sierżantowicz R; Lewko J; Jurkowska G
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32545800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Association between
    Kim YA; Cho YJ; Kwak SG
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32272678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries.
    Tack J; Stanghellini V; Mearin F; Yiannakou Y; Layer P; Coffin B; Simren M; Mackinnon J; Wiseman G; Marciniak A;
    BMC Gastroenterol; 2019 May; 19(1):69. PubMed ID: 31064345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome.
    Lacy B; Ayyagari R; Guerin A; Lopez A; Shi S; Luo M
    Therap Adv Gastroenterol; 2019; 12():1756284818818326. PubMed ID: 30636972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.
    Zuckerman RM; Silton RL; Tu FF; Eng JS; Hellman KM
    Arch Womens Ment Health; 2018 Oct; 21(5):533-541. PubMed ID: 29525829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.
    Addante R; Naliboff B; Shih W; Presson AP; Tillisch K; Mayer EA; Chang L
    J Clin Gastroenterol; 2019 Apr; 53(4):e142-e149. PubMed ID: 29351154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The global impact of IBS: time to think about IBS-specific models of care?
    Corsetti M; Whorwell P
    Therap Adv Gastroenterol; 2017 Sep; 10(9):727-736. PubMed ID: 28932273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service.
    Soubieres A; Wilson P; Poullis A; Wilkins J; Rance M
    Frontline Gastroenterol; 2015 Oct; 6(4):246-251. PubMed ID: 28839818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mind-body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment.
    Phillips-Moore JS; Talley NJ; Jones MP
    Health Psychol Open; 2015 Jan; 2(1):2055102914564583. PubMed ID: 28070348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic burden of irritable bowel syndrome in China.
    Zhang F; Xiang W; Li CY; Li SC
    World J Gastroenterol; 2016 Dec; 22(47):10450-10460. PubMed ID: 28058026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome.
    Tao W; Dong X; Kong G; Fang P; Huang X; Bo P
    Gastroenterol Res Pract; 2016; 2016():9256209. PubMed ID: 27635130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common Functional Gastroenterological Disorders Associated With Abdominal Pain.
    Bharucha AE; Chakraborty S; Sletten CD
    Mayo Clin Proc; 2016 Aug; 91(8):1118-32. PubMed ID: 27492916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea.
    Novak KL; Jacob D; Kaplan GG; Boyce E; Ghosh S; Ma I; Lu C; Wilson S; Panaccione R
    Can J Gastroenterol Hepatol; 2016; 2016():4023065. PubMed ID: 27446838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.
    Nanayakkara WS; Skidmore PM; O'Brien L; Wilkinson TJ; Gearry RB
    Clin Exp Gastroenterol; 2016; 9():131-42. PubMed ID: 27382323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable bowel syndrome.
    Enck P; Aziz Q; Barbara G; Farmer AD; Fukudo S; Mayer EA; Niesler B; Quigley EM; Rajilić-Stojanović M; Schemann M; Schwille-Kiuntke J; Simren M; Zipfel S; Spiller RC
    Nat Rev Dis Primers; 2016 Mar; 2():16014. PubMed ID: 27159638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in Care for Patients with Irritable Bowel Syndrome in the United States.
    Lacy BE; Patel H; Guérin A; Dea K; Scopel JL; Alaghband R; Wu EQ; Mody R
    PLoS One; 2016; 11(4):e0154258. PubMed ID: 27116612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
    Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
    Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
    Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
    BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care charges for youth with newly diagnosed epilepsy.
    Ryan JL; McGrady ME; Guilfoyle SM; Junger K; Arnett AD; Modi AC
    Neurology; 2015 Aug; 85(6):490-7. PubMed ID: 26163432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.